Contract Service Directory

Rovi Pharma Industrial Services S.A.U.





Company Headquarters

C/Julián Camarillo 35
Madrid, 28037
Spain

Company Description

ROVI Pharma Industrial Services provides Contract Manufacturing Services for injectable (prefilled syringes and vials) and solid forms. FDA-approved & GMP-certified manufacturing plants. Our full custom manufacturing services cover Manufacturing, Packaging, and Testing & Release. We have annual capacity of 250 million prefilled syringes, 60 million vials, 3 billion tablets. We also offer aseptic filling service for sterile water for injection (sWFI) syringes with ICH stability data for lyophilized substances

Contract Service Directory

    Related Content

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      ADMA Biologics Enters Mfg. and Supply Agreement

      ADMA Biologics Enters Mfg. and Supply Agreement

      To produce and sell plasma-derived intermediate fractions.
      01.07.20

    • Breaking News | Promotions & Moves
      Agios Pharmaceuticals Appoints CSO

      Agios Pharmaceuticals Appoints CSO

      Dr. Car spent 25 years at Bristol-Myers Squibb and its legacy companies
      12.02.19

    • Cold Chain Management | Logistics | Serialization | Supply Chain

      Review of FDA DSCSA Guidance Documents

      Brian Daleiden of TraceLink reviews the latest requirements from the FDA and DSCSA


    • Pharma Packaging Solutions

      Pharma Packaging Solutions

      PPS is a turn-key contract packager offering bottling, blister packaging, folding carton production, kitting, as well as vial/ampule and parenteral labeling.
      10.24.19

    • Regulatory Affairs
      Inactive Ingredients: Where Guidance Needs to Meet Data

      Inactive Ingredients: Where Guidance Needs to Meet Data

      Looking at FDA’s most recent draft guidance and the struggle with inactive ingredients.
      Sharif Ahmed, Lachman Consultants Services 10.15.19

    • Bio News | Breaking News | Facilities | Industry News
      GSK Invests $120M in Next-Gen US Bio Manufacturing Facility

      GSK Invests $120M in Next-Gen US Bio Manufacturing Facility

      Part of nearly $400 million in US manufacturing investments to deliver on the company’s pipeline
      09.30.19


    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • Trials & Filings
      FDA Approves New Treatment for Drug-Resistant TB

      FDA Approves New Treatment for Drug-Resistant TB

      Pretomanid is only the third new anti-TB drug approved by FDA in more than 40 years
      08.15.19


    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19